Discover how targeting Coenzyme A biosynthesis in malaria parasites offers promising new strategies for antimalarial drug development and transmission blocking.
Exploring how proteomics and metabolomics are revolutionizing antimalarial drug discovery by identifying novel molecular targets in malaria parasites.
Discover how scientists developed Plasmodium falciparum protease inhibitors between 2002-2012 to combat malaria by targeting the parasite's digestive machinery.